The Effect of Glucomannan Powder on Improving Gut Microbiota.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-28

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The object of this study is evaluating the effects of the Glucommanan on the healthy human subjects who are. In this trial, at most 30 healthy subjects whose ages are 20\~65 years old (15 for placebo and 15 for intervention)will be included. The total experiment will be 9 weeks and the intervention period will be 6 weeks, within which, at week 0, 6, and 7, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), aspartate aminotransferase (AST, also known as GOT), alanine aminotransferase (ALT, also known as GPT), blood urea nitrogen (BUN), serum creatinine (Cr), fasting blood glucose (Glucose, AC) and adiponectin would be measured. Feces samples and anthropometric data will also be acquired. The results will be analyzed according to the methods published by the Ministry of Health and Welfare of Taiwan Food and Drug Administration.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of a GLP-1 Formula Drink on Gut Microbiota and Glycemic Control in Prediabetic Individuals

NCT07089732

Obesity Prediabetes

NOT_YET_RECRUITING NA

Reduction of the Dietary Glycemic Index (GI) by L-Arabinose and Indigestible Dextrin

NCT01039662

Healthy

COMPLETED NA

Evaluation of VEDAN RT-90 Resistant Cassava Starch for Glycemic Control and Prebiotic Fiber Development in a Human Trial

NCT07282496

Resistant Starch Tapioca Starch Prebiotic Fiber +1 more

NOT_YET_RECRUITING NA

Type 2 Diabetes Intervention by Gut Microbiota-directed Diet -a Open Labelled RCT

NCT05541237

Type 2 Diabetes

UNKNOWN NA

Effects of Konjac Glucomannan Noodle Intervention in Subjects With Metabolic Syndrome

NCT02711306

Metabolic Syndrome

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dysbiosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo group

2 packs of corn starch daily

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

2 packs of corn starch, 2 grams per pack

Intervention group

2 packs of glucomannan powder daily

Group Type EXPERIMENTAL

Glucomannan

Intervention Type DIETARY_SUPPLEMENT

2 packs of glucomannan, 2 grams per pack

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Glucomannan

2 packs of glucomannan, 2 grams per pack

Intervention Type DIETARY_SUPPLEMENT

Placebo

2 packs of corn starch, 2 grams per pack

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Both genders, aged between 20 and 65 years.

No history of gastrointestinal disorders or other significant health issues.

Overall good health.

Exclusion Criteria

\- Participants who have taken antibiotics or any medications/supplements that could affect the gut microbiota within 1 week prior to the experiment or during the study.

Pregnant or breastfeeding women.

Smokers or individuals with excessive alcohol consumption.

Chronic disease medication usage for less than 3 months.

Postmenopausal women on hormone replacement therapy.

Individuals with acute illnesses such as a cold.

Minimum Eligible Age

20 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes